top of page
Safestra for Investors
Safestra Solutions: A Platform Play in IV Therapy Safety
Safestra Solutions is building a focused technology platform addressing error-prone moments in intravenous therapy through clinician-aligned hardware and software systems.
Rather than approaching IV safety as a single-product opportunity, Safestra is structured to develop and commercialize multiple interoperable solutions targeting different points of failure within the IV workflow.
Why This Category Is Underserved
IV therapy sits at an unusual intersection:
-
It is ubiquitous across care settings
-
It carries meaningful clinical and legal risk
-
It remains largely manual and dependent on human vigilance
Historically, innovation in this space has been fragmented, addressing isolated steps without addressing cumulative risk or cognitive burden.
Safestra’s thesis is that incremental safeguards at the right moments compound into meaningful system-level risk reduction.
Dr. Yahia Zine, CEO & Founder, demonstrating DVI-Station during an FMSQ filming session.
Why Now
IV therapy remains one of the most frequent clinical acts, yet safety infrastructure has not kept pace with growing complexity, staffing constraints, and liability exposure. This gap creates a rare opportunity for system-level innovation.
Investor Engagement
Safestra welcomes conversations with aligned investors as it advances its clinical and commercialization roadmap.
For further information or interest, please contact us at investors@safestrasolutions.com. We'll be happy to discuss more!
Alternatively, you may schedule a brief introductory meeting here.
bottom of page